Latest Insider Transactions at Pep Gen Inc. (PEPG)
This section provides a real-time view of insider transactions for Pep Gen Inc. (PEPG). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of PepGen Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of PepGen Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 03
2025
|
Mary Beth De Lena General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
13,400
+47.24%
|
-
|
|
Mar 03
2025
|
Paul Streck EVP, Head of R&D |
BUY
Grant, award, or other acquisition
|
Direct |
19,430
+50.0%
|
-
|
|
Mar 03
2025
|
Noel Donnelly Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
23,283
+48.27%
|
-
|
|
Mar 03
2025
|
James G Mc Arthur President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
60,719
+49.31%
|
-
|
|
Feb 26
2025
|
Mary Beth De Lena General Counsel |
SELL
Open market or private sale
|
Direct |
1,432
-47.73%
|
$1,432
$1.68 P/Share
|
|
Feb 26
2025
|
Noel Donnelly Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,527
-47.72%
|
$1,527
$1.68 P/Share
|
|
Feb 24
2025
|
Mary Beth De Lena General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+50.0%
|
-
|
|
Feb 24
2025
|
Noel Donnelly Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,200
+50.0%
|
-
|
|
Jul 25
2024
|
Michelle L Mellion Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,571
-100.0%
|
$136,278
$18.06 P/Share
|
|
Jul 25
2024
|
Michelle L Mellion Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,571
+50.0%
|
$75,710
$10.21 P/Share
|
|
Jul 24
2024
|
Michelle L Mellion Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
201
-100.0%
|
$3,618
$18.01 P/Share
|
|
Jul 24
2024
|
Michelle L Mellion Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
201
+50.0%
|
$2,010
$10.21 P/Share
|
|
Jul 18
2024
|
Michelle L Mellion Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
12,625
-100.0%
|
$227,250
$18.2 P/Share
|
|
Jul 18
2024
|
Michelle L Mellion Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,625
+50.0%
|
$126,250
$10.21 P/Share
|
|
Jul 16
2024
|
Michelle L Mellion Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,901
-100.0%
|
$106,218
$18.0 P/Share
|
|
Jul 16
2024
|
Michelle L Mellion Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,901
+50.0%
|
$59,010
$10.21 P/Share
|
|
Jul 12
2024
|
Michelle L Mellion Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,288
-100.0%
|
$59,184
$18.04 P/Share
|
|
Jul 12
2024
|
Michelle L Mellion Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,288
+50.0%
|
$32,880
$10.21 P/Share
|
|
Jul 02
2024
|
Michelle L Mellion Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
37
-100.0%
|
$666
$18.07 P/Share
|
|
Jul 02
2024
|
Michelle L Mellion Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
37
+50.0%
|
$370
$10.21 P/Share
|
|
Jul 01
2024
|
Michelle L Mellion Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
875
-100.0%
|
$15,750
$18.01 P/Share
|
|
Jul 01
2024
|
Michelle L Mellion Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
875
+50.0%
|
$8,750
$10.21 P/Share
|
|
Jun 24
2024
|
Michelle L Mellion Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
9,260
-100.0%
|
$166,680
$18.19 P/Share
|
|
Jun 24
2024
|
Michelle L Mellion Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,260
+50.0%
|
$92,600
$10.21 P/Share
|
|
Jun 12
2024
|
Michelle L Mellion Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,086
-100.0%
|
$19,548
$18.06 P/Share
|
|
Jun 12
2024
|
Michelle L Mellion Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,086
+50.0%
|
$10,860
$10.21 P/Share
|
|
Jun 11
2024
|
Michelle L Mellion Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
500
-100.0%
|
$9,000
$18.04 P/Share
|
|
Jun 11
2024
|
Michelle L Mellion Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+50.0%
|
$5,000
$10.21 P/Share
|
|
Jun 06
2024
|
Michelle L Mellion Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,411
-100.0%
|
$25,398
$18.0 P/Share
|
|
Jun 06
2024
|
Michelle L Mellion Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,411
+50.0%
|
$14,110
$10.21 P/Share
|
|
Jun 05
2024
|
Michelle L Mellion Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,245
-100.0%
|
$130,410
$18.09 P/Share
|
|
Jun 05
2024
|
Michelle L Mellion Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,245
+50.0%
|
$72,450
$10.21 P/Share
|
|
May 17
2024
|
Niels Svenstrup SVP, Chem. Mfg & Controls |
SELL
Open market or private sale
|
Direct |
10,000
-100.0%
|
$130,000
$13.41 P/Share
|
|
Feb 09
2024
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
2,557,593
+21.79%
|
$25,575,930
$10.64 P/Share
|
|
Nov 30
2023
|
James G Mc Arthur President and CEO |
BUY
Open market or private purchase
|
Direct |
1,694
+50.0%
|
$6,776
$4.17 P/Share
|
|
Jun 08
2023
|
James G Mc Arthur President and CEO |
SELL
Open market or private sale
|
Direct |
2,381
-100.0%
|
$38,096
$16.04 P/Share
|
|
Jun 08
2023
|
James G Mc Arthur President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,381
+50.0%
|
$4,762
$2.71 P/Share
|
|
Jun 07
2023
|
James G Mc Arthur President and CEO |
SELL
Open market or private sale
|
Direct |
8,419
-100.0%
|
$134,704
$16.23 P/Share
|
|
Jun 07
2023
|
James G Mc Arthur President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,419
+50.0%
|
$16,838
$2.71 P/Share
|
|
Jun 06
2023
|
James G Mc Arthur President and CEO |
SELL
Open market or private sale
|
Direct |
18,150
-100.0%
|
$290,400
$16.18 P/Share
|
|
Jun 06
2023
|
James G Mc Arthur President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
18,150
+50.0%
|
$36,300
$2.71 P/Share
|
|
Jun 05
2023
|
James G Mc Arthur President and CEO |
SELL
Open market or private sale
|
Direct |
500
-100.0%
|
$8,000
$16.06 P/Share
|
|
Jun 05
2023
|
James G Mc Arthur President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+50.0%
|
$1,000
$2.71 P/Share
|
|
Jun 02
2023
|
James G Mc Arthur President and CEO |
SELL
Open market or private sale
|
Direct |
1,800
-100.0%
|
$28,800
$16.04 P/Share
|
|
Jun 02
2023
|
James G Mc Arthur President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,800
+50.0%
|
$3,600
$2.71 P/Share
|
|
Mar 24
2023
|
Jaya Goyal EVP, Res. & Preclin. Dev. |
SELL
Open market or private sale
|
Direct |
392
-100.0%
|
$7,840
$20.0 P/Share
|
|
Mar 24
2023
|
Jaya Goyal EVP, Res. & Preclin. Dev. |
BUY
Exercise of conversion of derivative security
|
Direct |
392
+50.0%
|
$3,920
$10.88 P/Share
|
|
Feb 08
2023
|
Jaya Goyal EVP, Res. & Preclin. Dev. |
SELL
Open market or private sale
|
Direct |
644
-100.0%
|
$10,948
$17.0 P/Share
|
|
Feb 08
2023
|
Jaya Goyal EVP, Res. & Preclin. Dev. |
BUY
Exercise of conversion of derivative security
|
Direct |
644
+50.0%
|
$6,440
$10.88 P/Share
|
|
Feb 07
2023
|
Jaya Goyal EVP, Res. & Preclin. Dev. |
SELL
Open market or private sale
|
Direct |
3,679
-100.0%
|
$62,543
$17.18 P/Share
|